[1-[3-(3,4-dihydro-2H-1,5-naphthyridin-1-yl)-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazin-6-yl]-4-methoxypiperidin-4-yl]methylcarbamic acid
C26H34N8O4 — CID 135387949
Data last refreshed: (MolForge compound catalog, from PubChem)
About [1-[3-(3,4-dihydro-2H-1,5-naphthyridin-1-yl)-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazin-6-yl]-4-methoxypiperidin-4-yl]methylcarbamic acid
[1-[3-(3,4-dihydro-2H-1,5-naphthyridin-1-yl)-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazin-6-yl]-4-methoxypiperidin-4-yl]methylcarbamic acid (PubChem CID 135387949) has the molecular formula C26H34N8O4 and a molecular weight of 522.61 g/mol. Its IUPAC name is [1-[3-(3,4-dihydro-2H-1,5-naphthyridin-1-yl)-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazin-6-yl]-4-methoxypiperidin-4-yl]methylcarbamic acid.
Molecular Properties
| Compound Name | [1-[3-(3,4-dihydro-2H-1,5-naphthyridin-1-yl)-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazin-6-yl]-4-methoxypiperidin-4-yl]methylcarbamic acid |
|---|---|
| PubChem CID | 135387949 |
| Molecular Formula | C26H34N8O4 |
| Molecular Weight | 522.61 g/mol |
| Exact Mass | 522.27 |
| IUPAC Name | [1-[3-(3,4-dihydro-2H-1,5-naphthyridin-1-yl)-1-(oxan-2-yl)pyrazolo[3,4-b]pyrazin-6-yl]-4-methoxypiperidin-4-yl]methylcarbamic acid |
| SMILES | COC1(CNC(=O)O)CCN(c2cnc3c(N4CCCc5ncccc54)nn(C4CCCCO4)c3n2)CC1 |
| InChI | InChI=1S/C26H34N8O4/c1-37-26(17-29-25(35)36)9-13-32(14-10-26)20-16-28-22-23(30-20)34(21-8-2-3-15-38-21)31-24(22)33-12-5-6-18-19(33)7-4-11-27-18/h4,7,11,16,21,29H,2-3,5-6,8-10,12-15,17H2,1H3,(H,35,36) |
| InChIKey | GHYXBRDBIAAICG-UHFFFAOYSA-N |
| XLogP | 3.26 |
| TPSA | 130.76 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 522.61 |
| LogP ≤ 5 | 3.26 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135387949 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.